Talha Munir, MBBS, Leeds Teaching Hospitals NHS Trust, Leeds, UK, discusses a session on navigating patient burden in paroxysmal nocturnal hemoglobinuria (PNH), focusing on patient-reported outcomes (PROs). Dr Munir highlights that real-world data differs significantly from trial data due to factors such as the difference in the length of follow-up. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.